Lebrikizumab
Lilly buys three vaccine drugmakers in deals worth up to US$ 3.8 bn; FDA approves AbbVie’s ultra rare blood cancer drug

Lilly buys three vaccine drugmakers in deals worth up to US$ 3.8 bn; FDA approves AbbVie’s ultra rare blood cancer drug

Buoyed by the rising sales of its obesity drug, Eli Lilly has been on an acquisition spree this year. The company announced ag...

Impressions : 1555

FDA approves J&J’s plaque psoriasis pill; federal judge blocks key parts of RFK Jr’s childhood vaccine policy overhaul

FDA approves J&J’s plaque psoriasis pill; federal judge blocks key parts of RFK Jr’s childhood vaccine policy overhaul

As the war in the Middle East intensifies, the world is facing disruption of major air and sea routes. The war is already disr...

Impressions : 1276

FDA panel votes against Intercept’s liver med Ocaliva; Lilly’s Ebglyss wins approval for eczema

FDA panel votes against Intercept’s liver med Ocaliva; Lilly’s Ebglyss wins approval for eczema

Intercept Pharmaceuticals faced a major setback as a US Food and Drug Administration (FDA) panel voted against the confirmato...

Impressions : 1209

China to work with EU on aligning API standards; Lupin stumbles with FDA yet again

This week, Phispers has news from China, where its drug regulator said it would work with European Commission’s drug regu...

Impressions : 2243